AngioDynamics, Inc.ANGO has initiated the RECOVER-AV clinical trial, a prospective, multinational, single-arm study aimed at assessing the efficacy, safety and long-term outcomes of the AlphaVac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results